Table 3 BSS: balanced salt solution; DMSO: dimethyl sulfoxide
From: In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus
Group | Medication | Apoptotic cells (%) |
|---|---|---|
1 | 12.5 µL/mL liposome-encapsulated sirolimus | 0.46 ± 0.01 |
2 | 25 µL/mL liposome-encapsulated sirolimus | 0.46 ± 0.01 |
3 | 50 µL/mL liposome-encapsulated sirolimus | 0.45 ± 0.01 |
4 | 12.5 µL/mL empty liposomes | 0.45 ± 0.01 |
5 | 25 µL/mL empty liposomes | 0.45 ± 0.01 |
6 | 50 µL/mL empty liposomes | 0.45 ± 0.01 |
7 | 50 µL/mL BSS | 0.45 ± 0.01 |
8 | 50 µL/mL DMSO | 70.14 ± 3.05 |